|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Dec 31, 2025
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
Q1 FY2025
As of Dec 31, 2024
|
Q4 FY2024
As of Sep 30, 2024
|
Q3 FY2024
As of Jun 30, 2024
|
Q2 FY2024
As of Mar 31, 2024
|
Q1 FY2024
As of Dec 31, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jun 30, 2023
|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||
| Investments at fair value | |||||||||||||||
| Control investments | |||||||||||||||
| Affiliate investments | |||||||||||||||
| Non-control/Non-affiliate investments | |||||||||||||||
| Total investments at fair value | |||||||||||||||
| Cash and cash equivalents | |||||||||||||||
| Restricted cash | |||||||||||||||
| Interest, dividends and fees receivable | |||||||||||||||
| Due from portfolio companies | |||||||||||||||
| Receivables from unsettled transactions | |||||||||||||||
| Due from broker | |||||||||||||||
| Deferred financing costs | |||||||||||||||
| Deferred offering costs | |||||||||||||||
| Deferred tax asset, net | |||||||||||||||
| Derivative assets at fair value | |||||||||||||||
| Derivative asset at fair value | |||||||||||||||
| Other assets | |||||||||||||||
| Total assets | |||||||||||||||
| Liabilities: | |||||||||||||||
| Accounts payable, accrued expenses and other liabilities | |||||||||||||||
| Base management fee and incentive fee payable | |||||||||||||||
| Due to affiliate | |||||||||||||||
| Interest payable | |||||||||||||||
| Director fees payable | |||||||||||||||
| Payables from unsettled transactions | |||||||||||||||
| Derivative liabilities at fair value | |||||||||||||||
| Deferred tax liability | |||||||||||||||
| Credit facilities payable | |||||||||||||||
| Unsecured notes payable (net of $4,954 and $6,561 of unamortized financing costs as of June 30, 2026 and September 30, 2025, respectively) | |||||||||||||||
| Total liabilities | |||||||||||||||
| Net assets: | |||||||||||||||
| Common stock, $0.01 par value per share, 250,000 shares authorized; 88,086 shares issued and outstanding as of June 30, 2026 and September 30, 2025 | |||||||||||||||
| Additional paid-in-capital | |||||||||||||||
| Accumulated overdistributed earnings | |||||||||||||||
| Total net assets (equivalent to $15.70 and $16.64 per common share as of June 30, 2026 and September 30, 2025, respectively) (Note 11) | |||||||||||||||
| Additional paid-in-capital |
Loading...
